Matthew S. Holt

Director, Bellerophon Therapeutics (United States).

Companies

R1 RCM Inc. /DEBoard member Jun 23, 2022 to Nov 19, 2024¹
Signify Health, Inc.Board member Feb 10, 2021 to Mar 29, 2023²
AvantorBoard member May 16, 2019 to May 16, 2022³
Bellerophon Therapeutics (United States)Board member Feb 13, 2015 to Jun 21, 2016⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Avantor AVTR7,908 shares⁵$129.0K at $16.31May 12, 2022
Signify Health, Inc.0 shares⁶Mar 29, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 29, 2023Returned to company 14,672 shares of Signify Health, Inc.⁶
May 19, 2022Granted 14,672 shares of Signify Health, Inc.⁷
May 12, 2022Granted 6,693 shares of Avantor⁵
Apr 1, 2022Granted 1,215 shares of Avantor⁸
Feb 16, 2022Other 7,916 shares of Signify Health, Inc.⁹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARR1 RCM Inc. /DE, Board member
2
SEC EDGARSignify Health, Inc., Board member
3
SEC EDGARAvantor, Board member
4
SEC EDGARBellerophon Therapeutics (United States), Board member
5
SEC EDGARAvantor shares after the filing of May 12, 2022
6
SEC EDGARSignify Health, Inc. shares after the filing of Mar 29, 2023
7
SEC EDGARForm 4 filed May 23, 2022
8
SEC EDGARForm 4 filed Apr 5, 2022
9
SEC EDGARForm 4 filed Feb 18, 2022